Your browser doesn't support javascript.
loading
Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer.
Kim, Choung Soo; Choi, Young Deuk; Lee, Sang Eun; Lee, Hyun Moo; Ueda, Takeshi; Yonese, Junji; Fukagai, Takashi; Chiong, Edmund; Lau, Weber; Abhyankar, Sarang; Theeuwes, Ad; Tombal, Bertrand; Beer, Tomasz M; Kimura, Go.
Afiliação
  • Kim CS; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine Department of Urology, Yonsei University College of Medicine Department of Urology, Seoul National University Bundang Hospital Department of Urology, Samsung Medical Center, Seoul, Korea Prostate Center and Division of Urology, Chiba Cancer Center, Chiba Department of Urology, Cancer Institute Hospital of Japanese Foundation for Cancer Research Department of Urology, Showa University Koto Toyosu Hospital, Tokyo,
Medicine (Baltimore) ; 96(27): e7223, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28682871
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article